• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
      • SAGES Robotics Residents and Fellows Courses
      • MIS Fellows Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / LAPAROSCOPIC PARENCHYMAL SPARING LIVER RESECTIONS — ARE THEY FEASIBLE? A SYSTEMATIC REVIEW AND META-ANALYSIS

LAPAROSCOPIC PARENCHYMAL SPARING LIVER RESECTIONS — ARE THEY FEASIBLE? A SYSTEMATIC REVIEW AND META-ANALYSIS

Jennifer A Kalil, MD, Erik Schadde, MD, FACS, FEBS. Rush University Medical Center

Introduction: Liver resection with preservation of as much liver parenchyma as possible is called parenchymal sparing hepatectomy (PSH). PSH has been shown to improve overall survival by increasing the re-resection rate in patients with colorectal liver metastases (CRLM) and recurrence. The caudal-cranial perspective in laparoscopy makes the cranial segments (2, 4a, 7, and 8) more difficult to access. The objective of this systematic review is to analyze feasibility, safety, morbidity, and oncologic outcomes of laparoscopic PSH. 

Methods: A systematic review of the literature was performed. Medline/PubMed, Scopus, and Cochrane databases were searched. A search strategy was published with the PROSPERO registry. A systematic review was conducted on all cases reported, they were categorized by area of resection and quantitative meta-analysis of operative time, blood loss, length of hospital stay, complications, and R0 resection was performed. 

Results: Of the 351 studies screened for relevance, 48 studies were selected. Because interventions or endpoints were noncontributory or reporting incomplete, 38 were excluded. Only 10 publications remained, reporting data from 579 patients who underwent laparoscopic PSH. The highest Oxford evidence level was 2b and selective reporting bias was common due to single center and non-controlled reports. Among them, 132 (21.5%) resections were in the cranial segments 2 (1.1%), 4a (5.2%), 7 (6%), and 8 (9.1%), which previously would have required laparoscopic hemi-hepatectomies or sectorectomies. The most common tumor type was CRLM (58%) and the second most common tumor type was hepatocellular carcinoma (16%). Feasibility of laparoscopic PSH was 93%, conversion rate was 7%, and complications were seen in 17% of cases. No perioperative mortality was reported. No standardized reporting format for complications was used across studies. Meta-analysis revealed a weighted average operating time of 385 minutes, estimated blood loss of 463 cc, and length of stay of 8 days. R0 resections were achieved in 91% of cases. 

Conclusion: Laparoscopic PSH of difficult to reach liver tumors are feasible with acceptable conversion and complication rate, but relatively long operating times and relatively high blood loss. In future studies, data on long term survival and specific tumor type recurrence should be reported and bias reduced. 


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 86327

Program Number: P537

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

84

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon

Related



Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals